Cho Yongkeun
Department of Internal Medicine Kyungpook National University Hospital Daegu Korea.
J Arrhythm. 2018 Mar 11;34(4):356-368. doi: 10.1002/joa3.12012. eCollection 2018 Aug.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive cardiomyopathy characterized by fibrofatty infiltration of the myocardium, ventricular arrhythmias, sudden death, and heart failure. ARVC may be an important cause of syncope, sudden death, ventricular arrhythmias, and/or wall motion abnormalities, especially in the young. As the first symptom is sudden death or cardiac arrest in many cases, an early diagnosis and risk stratification are important. Recent advances in diagnostic modalities will be helpful in the early diagnosis and proper management of patients at risk. Restriction of strenuous exercise and implantation of implantable cardioverter-defibrillators are important in addition to medical treatment and catheter ablation of ventricular tachycardia. Recently introduced genetic screening may help to identify asymptomatic carriers with a risk of a disease progression and sudden death.
致心律失常性右室心肌病(ARVC)是一种进行性心肌病,其特征为心肌纤维脂肪浸润、室性心律失常、猝死和心力衰竭。ARVC可能是晕厥、猝死、室性心律失常和/或壁运动异常的重要原因,尤其是在年轻人中。由于在许多病例中首发症状是猝死或心脏骤停,早期诊断和风险分层很重要。诊断方法的最新进展将有助于对有风险的患者进行早期诊断和适当管理。除药物治疗和室性心动过速的导管消融外,限制剧烈运动和植入植入式心脏复律除颤器也很重要。最近引入的基因筛查可能有助于识别有疾病进展和猝死风险的无症状携带者。